Soy Isoflavones and Breast Cancer Risk Reduction

PHASE2CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

December 10, 2012

Study Completion Date

May 31, 2023

Conditions
Breast Cancer
Interventions
DIETARY_SUPPLEMENT

isoflavones

soy isoflavones: Each tablet contains 246 mg Novasoy, 676 mg calcium, 15 mg riboflavin, and other innert materials to a total weight of 1000 mg. Subject takes two isoflavone tablets plus 1 multi-vitamin per day for five days per week for upto 2 years.

DIETARY_SUPPLEMENT

carbohydrate

carbohydrate: 246 mg maltodextrin, 676 mg calcium, 15 mg riboflavin and other innert ingredients to a total weight of 1000 mg per tablet. subject takes two tablets plus one multivitamin per day for five days per week for upto 2 years.

Trial Locations (1)

77555-0264

General Clinical Reserach Center, The University of Texas Medical Branch, Galveston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

National Center for Research Resources (NCRR)

NIH

lead

The University of Texas Medical Branch, Galveston

OTHER

NCT00204490 - Soy Isoflavones and Breast Cancer Risk Reduction | Biotech Hunter | Biotech Hunter